Big Phar­mas team up with lo­cal Sin­ga­pore or­ga­ni­za­tions to boost man­u­fac­tur­ing

Sin­ga­pore has long es­tab­lished it­self as a ma­jor hub for phar­ma man­u­fac­tur­ing, and now sev­er­al big play­ers are look­ing to fur­ther ce­ment their pres­ence in the Li­on City.

Take­da, Sanofi and GSK are form­ing a part­ner­ship with the Sin­ga­pore-based Agency for Sci­ence, Tech­nol­o­gy and Re­search (A*STAR) and sev­er­al lo­cal aca­d­e­m­ic in­sti­tu­tions, in­clud­ing the Na­tion­al Uni­ver­si­ty of Sin­ga­pore, Nanyang Tech­no­log­i­cal Uni­ver­si­ty, Sin­ga­pore, its en­ter­prise com­pa­ny called NTU­itive and Sin­ga­pore In­sti­tute of Tech­nol­o­gy to pro­vide a greater boost to the man­u­fac­tur­ing of bi­o­log­ics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.